Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
1.080
0.00 (0.00%)
At close: Aug 21, 2026, 4:00 PM EDT
1.090
+0.010 (0.93%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Firefly Neuroscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1.81.140.110.5-0.03
Revenue Growth
320.33%957.41%-78.31%---
Cost of Revenue
10.5----
Gross Profit
0.80.650.110.5-0.03
Selling, General & Admin
7.867.727.332.842.071.76
Research & Development
1.781.481.950.741.32.93
Operating Expenses
9.649.29.293.583.374.69
Operating Income
-8.84-8.56-9.18-3.08-3.37-4.65
Interest Expense
-0.03-0.16-0.07-0.02-0.44-0.14
Interest & Investment Income
0.110.09----
Currency Exchange Gain (Loss)
-0-0.010.010.04-0.13-
Other Non Operating Income (Expenses)
-0.05-9.59-0.350.460.01-0
EBT Excluding Unusual Items
-8.81-18.22-9.58-2.6-3.93-4.79
Merger & Restructuring Charges
-0.05-0.05----
Gain (Loss) on Sale of Investments
-----0.55
Gain (Loss) on Sale of Assets
----0.170.31
Asset Writedown
-0.25-0.25-0.87--0.08-
Other Unusual Items
--1.35---0.06-0.45
Pretax Income
-9.11-19.88-10.46-2.6-3.9-4.38
Income Tax Expense
00.0100--
Net Income
-9.11-19.88-10.46-2.6-3.9-4.38
Preferred Dividends & Other Adjustments
0.334.65----
Net Income to Common
-9.44-24.53-10.46-2.6-3.9-4.38
Net Income Growth
------
Shares Outstanding (Basic)
1612731-
Shares Outstanding (Diluted)
1612731-
Shares Change
62.62%90.07%102.48%134.29%--
EPS (Basic)
-0.60-1.97-1.60-0.81-2.83-
EPS (Diluted)
-0.60-1.97-1.60-0.81-2.83-
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7.2-8.32-6.3-2.17-2.89-3.82
Free Cash Flow Per Share
-0.46-0.67-0.96-0.67-2.10-
Gross Margin
44.58%56.48%100.00%100.00%-100.00%
Operating Margin
-491.38%-749.12%-8500.00%-618.07%--14543.75%
Profit Margin
-524.51%-2148.07%-9685.18%-522.69%--13690.63%
Free Cash Flow Margin
-400.22%-728.72%-5836.11%-436.14%--11937.50%
EBITDA
-8.72-8.46-9.17-3.06-3.35-4.23
D&A For EBITDA
0.120.090.010.010.010.43
EBIT
-8.84-8.56-9.18-3.08-3.37-4.65
SEC Filings: 10-K · 10-Q